|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019134,
umls-concept:C0030705,
umls-concept:C0036186,
umls-concept:C0168273,
umls-concept:C0205108,
umls-concept:C0332835,
umls-concept:C0522523,
umls-concept:C0699733,
umls-concept:C1545588,
umls-concept:C1704311,
umls-concept:C1948041
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-6-27
|
|
pubmed:abstractText |
Bivalirudin (Angiomax) is increasingly used as a substitute for heparin in a variety of percutaneous coronary interventions, and data on its usage in saphenous vein graft interventions are limited. This retrospective, observational study evaluated the efficacy and safety of bivalirudin compared with heparin as an antithrombotic regimen in patients who underwent saphenous vein graft intervention with distal protection devices. We found that bivalirudin use is clinically safe and feasible, with fewer vascular and ischemic complications compared with heparin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0002-9149
|
|
pubmed:author |
pubmed-author:CheneauEdouardE,
pubmed-author:KentKenneth MKM,
pubmed-author:KuchulakantiPramod KPK,
pubmed-author:LindsayJosephJ,
pubmed-author:PakalaRajbabuR,
pubmed-author:PichardAugusto DAD,
pubmed-author:PinnowEllenE,
pubmed-author:RhaSeung-WoonSW,
pubmed-author:SatlerLowell FLF,
pubmed-author:SuddathWilliam OWO,
pubmed-author:TorgusonRebeccaR,
pubmed-author:WaksmanRonR
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
67-70
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15979436-Aged,
pubmed-meshheading:15979436-Aged, 80 and over,
pubmed-meshheading:15979436-Anticoagulants,
pubmed-meshheading:15979436-Antithrombins,
pubmed-meshheading:15979436-Coronary Artery Disease,
pubmed-meshheading:15979436-Female,
pubmed-meshheading:15979436-Heparin,
pubmed-meshheading:15979436-Hirudins,
pubmed-meshheading:15979436-Humans,
pubmed-meshheading:15979436-Male,
pubmed-meshheading:15979436-Middle Aged,
pubmed-meshheading:15979436-Peptide Fragments,
pubmed-meshheading:15979436-Postoperative Complications,
pubmed-meshheading:15979436-Recombinant Proteins,
pubmed-meshheading:15979436-Retrospective Studies,
pubmed-meshheading:15979436-Saphenous Vein,
pubmed-meshheading:15979436-Stents,
pubmed-meshheading:15979436-Thrombosis,
pubmed-meshheading:15979436-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device.
|
|
pubmed:affiliation |
Division of Cardiology, Washington Hospital Center, Washington, DC, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|
